SPOTLIGHT -
Alexander Kolevzon, MD: The STARS Study in Angelman Syndrome
The director of Child and Adolescent Psychiatry at Mount Sinai Health System spoke about the results of the phase 2 study of OV101 (gaboxadol), and the next steps for the phase 3 trial.